NM_001492.6(GDF1):c.985C>T (p.Pro329Ser) |
single nucleotide variant |
GDF1-related disorder [RCV003419979]|not provided [RCV002530186]|not specified [RCV004024189] |
Chr19:18868731 [GRCh38] Chr19:18979540 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.120C>T (p.Leu40=) |
single nucleotide variant |
not provided [RCV002530182] |
Chr19:18870188 [GRCh38] Chr19:18980997 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.658C>A (p.Arg220Ser) |
single nucleotide variant |
not provided [RCV002530183]|not specified [RCV004024188] |
Chr19:18869058 [GRCh38] Chr19:18979867 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1018C>G (p.Leu340Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000553878] |
Chr19:18870612 [GRCh38] Chr19:18981421 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.788C>T (p.Pro263Leu) |
single nucleotide variant |
not provided [RCV002530184] |
Chr19:18868928 [GRCh38] Chr19:18979737 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1044CTT[1] (p.Phe350del) |
microsatellite |
Progressive myoclonic epilepsy type 8 [RCV001316710]|Visceral heterotaxy [RCV000545548] |
Chr19:18868667..18868669 [GRCh38] Chr19:18979476..18979478 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.857C>T (p.Ala286Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000547849]|not specified [RCV004024317] |
Chr19:18879284 [GRCh38] Chr19:18990093 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.906C>T (p.Ile302=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000542274] |
Chr19:18879034 [GRCh38] Chr19:18989843 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.398C>T (p.Ser133Phe) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000557445] |
Chr19:18893427 [GRCh38] Chr19:19004236 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.437G>A (p.Arg146Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000545139] |
Chr19:18884240 [GRCh38] Chr19:18995049 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.137G>C (p.Arg46Pro) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV001196855] |
Chr19:18870171 [GRCh38] Chr19:18980980 [GRCh37] Chr19:19p13.11 |
uncertain significance |
GRCh38/hg38 19p13.11-q13.11(chr19:17176767-34924150)x3 |
copy number gain |
See cases [RCV000050635] |
Chr19:17176767..34924150 [GRCh38] Chr19:17287576..35415054 [GRCh37] Chr19:17148576..40106894 [NCBI36] Chr19:19p13.11-q13.11 |
pathogenic |
GRCh38/hg38 19p13.12-q11(chr19:13974677-27839676)x3 |
copy number gain |
See cases [RCV000052912] |
Chr19:13974677..27839676 [GRCh38] Chr19:14085489..28330584 [GRCh37] Chr19:13946489..33022424 [NCBI36] Chr19:19p13.12-q11 |
pathogenic |
NM_001492.6(GDF1):c.681C>A (p.Cys227Ter) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV000007139]|GDF1-RELATED DISORDERS [RCV003335019]|GDF1-related disorder [RCV003407289]|Right atrial isomerism [RCV000055615]|Right atrial isomerism [RCV005025024]|Transposition of the great arteries [RCV004576881]|not provided [RCV000417815] |
Chr19:18869035 [GRCh38] Chr19:18979844 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic|likely benign |
NM_001492.6(GDF1):c.800G>A (p.Cys267Tyr) |
single nucleotide variant |
Double outlet right ventricle [RCV000007140]|GDF1-related disorder [RCV003421909] |
Chr19:18868916 [GRCh38] Chr19:18979725 [GRCh37] Chr19:19p13.11 |
pathogenic|uncertain significance |
NM_001492.6(GDF1):c.485G>A (p.Gly162Asp) |
single nucleotide variant |
GDF1-related disorder [RCV003924808]|Progressive myoclonic epilepsy type 8 [RCV005089199]|Tetralogy of Fallot [RCV000007141]|not provided [RCV000180221] |
Chr19:18869231 [GRCh38] Chr19:18980040 [GRCh37] Chr19:19p13.11 |
pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_001492.6(GDF1):c.-894A>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000534769]|not specified [RCV000125216] |
Chr19:18884248 [GRCh38] Chr19:18995057 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.-422-11C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002055555]|not provided [RCV004717013]|not specified [RCV000125217] |
Chr19:18879050 [GRCh38] Chr19:18989859 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.325+20G>A |
single nucleotide variant |
not provided [RCV002514671]|not specified [RCV000125218] |
Chr19:18869963 [GRCh38] Chr19:18980772 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.-1089T>C |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001518081]|not provided [RCV001535130]|not specified [RCV000125219] |
Chr19:18895839 [GRCh38] Chr19:19006648 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.909dup (p.Val304fs) |
duplication |
Right atrial isomerism [RCV000055616]|not provided [RCV001311505] |
Chr19:18868806..18868807 [GRCh38] Chr19:18979615..18979616 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic |
NM_001492.5(GDF1):c.470_471insGGC (p.Ala158_Pro159insAla) |
insertion |
not specified [RCV000180220] |
Chr19:18869245..18869246 [GRCh38] Chr19:18980054..18980055 [GRCh37] Chr19:19p13.11 |
benign |
GRCh38/hg38 19p13.2-q13.31(chr19:11227942-44626354)x3 |
copy number gain |
See cases [RCV000133888] |
Chr19:11227942..44626354 [GRCh38] Chr19:11338618..45129651 [GRCh37] Chr19:11199618..49821491 [NCBI36] Chr19:19p13.2-q13.31 |
pathogenic |
GRCh38/hg38 19p13.12-12(chr19:15133594-24193591)x3 |
copy number gain |
See cases [RCV000136696] |
Chr19:15133594..24193591 [GRCh38] Chr19:15244405..24376393 [GRCh37] Chr19:15105405..24168233 [NCBI36] Chr19:19p13.12-12 |
pathogenic|likely pathogenic |
NM_021267.5(CERS1):c.549C>G (p.His183Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000161146] |
Chr19:18884128 [GRCh38] Chr19:18994937 [GRCh37] Chr19:19p13.11 |
pathogenic|not provided |
NM_001492.6(GDF1):c.326-14T>C |
single nucleotide variant |
not provided [RCV001706151]|not specified [RCV000253466] |
Chr19:18869404 [GRCh38] Chr19:18980213 [GRCh37] Chr19:19p13.11 |
benign|uncertain significance |
NM_001492.6(GDF1):c.456GGC[6] (p.Ala158_Pro159insAla) |
microsatellite |
Progressive myoclonic epilepsy type 8 [RCV000860512]|Visceral heterotaxy [RCV000200398]|not provided [RCV001640299]|not specified [RCV000180220] |
Chr19:18869245..18869246 [GRCh38] Chr19:18980054..18980055 [GRCh37] Chr19:19p13.11 |
benign |
NM_021267.5(CERS1):c.37C>T (p.Pro13Ser) |
single nucleotide variant |
CERS1-related disorder [RCV003935533]|Progressive myoclonic epilepsy type 8 [RCV000547172]|not specified [RCV004024315] |
Chr19:18896036 [GRCh38] Chr19:19006845 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_001492.6(GDF1):c.925T>C (p.Ser309Pro) |
single nucleotide variant |
GDF1-related disorder [RCV003947670]|not provided [RCV004701271]|not specified [RCV003323454] |
Chr19:18868791 [GRCh38] Chr19:18979600 [GRCh37] Chr19:19p13.11 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_021267.5(CERS1):c.550G>T (p.Val184Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000548766] |
Chr19:18884127 [GRCh38] Chr19:18994936 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.450C>T (p.Ala150=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000559940]|not provided [RCV002275088] |
Chr19:18884227 [GRCh38] Chr19:18995036 [GRCh37] Chr19:19p13.11 |
benign|likely benign |
NM_001492.6(GDF1):c.55C>G (p.Leu19Val) |
single nucleotide variant |
not provided [RCV000726820]|not specified [RCV000247373] |
Chr19:18870253 [GRCh38] Chr19:18981062 [GRCh37] Chr19:19p13.11 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_001492.6(GDF1):c.-11C>T |
single nucleotide variant |
not specified [RCV000245588] |
Chr19:18870318 [GRCh38] Chr19:18981127 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.353C>T (p.Ala118Val) |
single nucleotide variant |
not provided [RCV001668476]|not specified [RCV000245880] |
Chr19:18869363 [GRCh38] Chr19:18980172 [GRCh37] Chr19:19p13.11 |
benign|likely benign |
NM_001492.6(GDF1):c.388G>A (p.Val130Ile) |
single nucleotide variant |
not provided [RCV002519909]|not specified [RCV000250832] |
Chr19:18869328 [GRCh38] Chr19:18980137 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.780C>T (p.Gly260=) |
single nucleotide variant |
not provided [RCV000346250] |
Chr19:18868936 [GRCh38] Chr19:18979745 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.203G>A (p.Arg68His) |
single nucleotide variant |
not provided [RCV000314910] |
Chr19:18870105 [GRCh38] Chr19:18980914 [GRCh37] Chr19:19p13.11 |
uncertain significance |
GRCh37/hg19 19p13.11-11(chr19:16526787-24631604)x3 |
copy number gain |
not provided [RCV000752593] |
Chr19:16526787..24631604 [GRCh37] Chr19:19p13.11-11 |
pathogenic |
NM_021267.5(CERS1):c.492C>T (p.Tyr164=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000533843]|not provided [RCV002263809] |
Chr19:18884185 [GRCh38] Chr19:18994994 [GRCh37] Chr19:19p13.11 |
benign|likely benign |
NM_021267.5(CERS1):c.590+9A>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000527201] |
Chr19:18884078 [GRCh38] Chr19:18994887 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.371G>T (p.Cys124Phe) |
single nucleotide variant |
not provided [RCV000441370] |
Chr19:18869345 [GRCh38] Chr19:18980154 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
GRCh37/hg19 19p13.11(chr19:18136482-19087534)x3 |
copy number gain |
See cases [RCV000449006] |
Chr19:18136482..19087534 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.952G>A (p.Ala318Thr) |
single nucleotide variant |
not provided [RCV000481287] |
Chr19:18868764 [GRCh38] Chr19:18979573 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.190C>T (p.Arg64Cys) |
single nucleotide variant |
not provided [RCV002523325]|not specified [RCV004917637] |
Chr19:18870118 [GRCh38] Chr19:18980927 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1047_1050del (p.Phe349fs) |
deletion |
Congenital heart defects, multiple types, 6 [RCV002470862]|Right atrial isomerism [RCV005027530]|not provided [RCV000627519] |
Chr19:18868666..18868669 [GRCh38] Chr19:18979475..18979478 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic |
NM_001492.6(GDF1):c.404C>T (p.Ala135Val) |
single nucleotide variant |
not provided [RCV003654374]|not specified [RCV004022812] |
Chr19:18869312 [GRCh38] Chr19:18980121 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.401C>G (p.Ser134Trp) |
single nucleotide variant |
not provided [RCV000483872] |
Chr19:18869315 [GRCh38] Chr19:18980124 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.-1107C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001511468]|not provided [RCV004717606]|not specified [RCV000455238] |
Chr19:18895857 [GRCh38] Chr19:19006666 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.153T>G (p.Gly51=) |
single nucleotide variant |
not provided [RCV003766632] |
Chr19:18870155 [GRCh38] Chr19:18980964 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.537G>A (p.Gly179=) |
single nucleotide variant |
not provided [RCV002525682] |
Chr19:18869179 [GRCh38] Chr19:18979988 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.599G>A (p.Gly200Asp) |
single nucleotide variant |
Right atrial isomerism [RCV002489069]|not provided [RCV002523326]|not specified [RCV004022811] |
Chr19:18869117 [GRCh38] Chr19:18979926 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.776_801del (p.Leu259fs) |
deletion |
Right atrial isomerism [RCV003147471]|not provided [RCV000487281] |
Chr19:18868915..18868940 [GRCh38] Chr19:18979724..18979749 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_021267.5(CERS1):c.898C>T (p.Leu300=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000527412]|not provided [RCV001572993] |
Chr19:18879243 [GRCh38] Chr19:18990052 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1091T>C (p.Met364Thr) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV000625716]|Heart, malformation of [RCV001836851]|not provided [RCV000860460] |
Chr19:18868625 [GRCh38] Chr19:18979434 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic|benign|conflicting interpretations of pathogenicity |
NM_021267.5(CERS1):c.787G>A (p.Val263Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000537513]|not provided [RCV001507431]|not specified [RCV004024316] |
Chr19:18879354 [GRCh38] Chr19:18990163 [GRCh37] Chr19:19p13.11 |
uncertain significance |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888) |
copy number gain |
See cases [RCV000512296] |
Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-58956888)x3 |
copy number gain |
See cases [RCV000511289] |
Chr19:260912..58956888 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic|uncertain significance |
NM_001492.6(GDF1):c.1090_1092del (p.Met364del) |
deletion |
Right atrial isomerism [RCV000625715] |
Chr19:18868624..18868626 [GRCh38] Chr19:18979433..18979435 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.782T>C (p.Leu261Pro) |
single nucleotide variant |
not specified [RCV004325772] |
Chr19:18879359 [GRCh38] Chr19:18990168 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.329C>A (p.Ala110Glu) |
single nucleotide variant |
not specified [RCV004314159] |
Chr19:18869387 [GRCh38] Chr19:18980196 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.258G>A (p.Ala86=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000532300] |
Chr19:18893567 [GRCh38] Chr19:19004376 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.708T>A (p.His236Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652505]|not specified [RCV004025866] |
Chr19:18880318 [GRCh38] Chr19:18991127 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.257C>T (p.Ala86Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652506]|not provided [RCV001090560]|not specified [RCV004025867] |
Chr19:18893568 [GRCh38] Chr19:19004377 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.16C>A (p.Pro6Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652507]|not provided [RCV004704171]|not specified [RCV004025868] |
Chr19:18896057 [GRCh38] Chr19:19006866 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.164T>A (p.Leu55Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652508]|not specified [RCV004025869] |
Chr19:18895909 [GRCh38] Chr19:19006718 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.559C>G (p.Leu187Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652509] |
Chr19:18884118 [GRCh38] Chr19:18994927 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1011-2A>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652510] |
Chr19:18870621 [GRCh38] Chr19:18981430 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.901-3C>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652511] |
Chr19:18879042 [GRCh38] Chr19:18989851 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.178C>T (p.Leu60=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001438073] |
Chr19:18895895 [GRCh38] Chr19:19006704 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.912C>G (p.Val304=) |
single nucleotide variant |
GDF1-related disorder [RCV003962558]|not provided [RCV002530185] |
Chr19:18868804 [GRCh38] Chr19:18979613 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.477T>C (p.Tyr159=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652512] |
Chr19:18884200 [GRCh38] Chr19:18995009 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.834C>T (p.Ile278=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652513] |
Chr19:18879307 [GRCh38] Chr19:18990116 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.582C>T (p.Tyr194=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000652515]|not provided [RCV004704172] |
Chr19:18884095 [GRCh38] Chr19:18994904 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.883T>A (p.Tyr295Asn) |
single nucleotide variant |
not provided [RCV002530530] |
Chr19:18868833 [GRCh38] Chr19:18979642 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.549C>T (p.Leu183=) |
single nucleotide variant |
not provided [RCV002531933] |
Chr19:18869167 [GRCh38] Chr19:18979976 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.330G>T (p.Ala110=) |
single nucleotide variant |
not provided [RCV002531934] |
Chr19:18869386 [GRCh38] Chr19:18980195 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.326-8C>T |
single nucleotide variant |
not provided [RCV002531935] |
Chr19:18869398 [GRCh38] Chr19:18980207 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.159C>T (p.Pro53=) |
single nucleotide variant |
not provided [RCV002531936] |
Chr19:18870149 [GRCh38] Chr19:18980958 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.419C>T (p.Pro140Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000700377] |
Chr19:18884258 [GRCh38] Chr19:18995067 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.851T>C (p.Phe284Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000699010] |
Chr19:18879290 [GRCh38] Chr19:18990099 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.742G>A (p.Gly248Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000688590] |
Chr19:18880284 [GRCh38] Chr19:18991093 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.80C>T (p.Thr27Ile) |
single nucleotide variant |
not provided [RCV002536396] |
Chr19:18870228 [GRCh38] Chr19:18981037 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.181C>A (p.Leu61Met) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000685750] |
Chr19:18895892 [GRCh38] Chr19:19006701 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.685G>A (p.Gly229Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000693046]|not provided [RCV004692124]|not specified [RCV004025142] |
Chr19:18880341 [GRCh38] Chr19:18991150 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.23C>G (p.Ala8Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000705623] |
Chr19:18896050 [GRCh38] Chr19:19006859 [GRCh37] Chr19:19p13.11 |
uncertain significance |
GRCh37/hg19 19p13.3-q13.43(chr19:68029-59110290)x3 |
copy number gain |
not provided [RCV000752439] |
Chr19:68029..59110290 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
GRCh37/hg19 19p13.3-q13.43(chr19:260912-59097160)x3 |
copy number gain |
not provided [RCV000752444] |
Chr19:260912..59097160 [GRCh37] Chr19:19p13.3-q13.43 |
pathogenic |
NM_021267.5(CERS1):c.534C>G (p.Val178=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001446675] |
Chr19:18884143 [GRCh38] Chr19:18994952 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.876C>G (p.Thr292=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001440025] |
Chr19:18879265 [GRCh38] Chr19:18990074 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.357G>A (p.Ser119=) |
single nucleotide variant |
not provided [RCV002536219]|not specified [RCV004800615] |
Chr19:18869359 [GRCh38] Chr19:18980168 [GRCh37] Chr19:19p13.11 |
benign|likely benign |
NM_021267.5(CERS1):c.425T>A (p.Met142Lys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000986206] |
Chr19:18884252 [GRCh38] Chr19:18995061 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.663C>T (p.Leu221=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000924124] |
Chr19:18880363 [GRCh38] Chr19:18991172 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1029G>A (p.Ser343=) |
single nucleotide variant |
not provided [RCV005056646] |
Chr19:18868687 [GRCh38] Chr19:18979496 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.410-10C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000878154] |
Chr19:18884277 [GRCh38] Chr19:18995086 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.178C>G (p.Leu60Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001046911]|not specified [RCV004031458] |
Chr19:18895895 [GRCh38] Chr19:19006704 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.912G>A (p.Ala304=) |
single nucleotide variant |
CERS1-related disorder [RCV003903093]|Progressive myoclonic epilepsy type 8 [RCV000932995] |
Chr19:18879028 [GRCh38] Chr19:18989837 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.66A>G (p.Leu22=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000979453] |
Chr19:18896007 [GRCh38] Chr19:19006816 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1038C>T (p.Ser346=) |
single nucleotide variant |
not provided [RCV000875854] |
Chr19:18868678 [GRCh38] Chr19:18979487 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.522G>A (p.Lys174=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002542165] |
Chr19:18884155 [GRCh38] Chr19:18994964 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.752+9T>C |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002065493] |
Chr19:18880265 [GRCh38] Chr19:18991074 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.300C>T (p.Pro100=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001487568] |
Chr19:18893525 [GRCh38] Chr19:19004334 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.582G>A (p.Val194=) |
single nucleotide variant |
not provided [RCV000874890] |
Chr19:18869134 [GRCh38] Chr19:18979943 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.189G>A (p.Trp63Ter) |
single nucleotide variant |
not provided [RCV002535951] |
Chr19:18870119 [GRCh38] Chr19:18980928 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic |
NM_021267.5(CERS1):c.836C>G (p.Pro279Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000820978] |
Chr19:18879305 [GRCh38] Chr19:18990114 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.222C>G (p.Arg74=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000799742] |
Chr19:18895851 [GRCh38] Chr19:19006660 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.557C>T (p.Thr186Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000821365] |
Chr19:18884120 [GRCh38] Chr19:18994929 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.5CGG[4] (p.Ala4_Gly5insAla) |
microsatellite |
Progressive myoclonic epilepsy type 8 [RCV000821760] |
Chr19:18896059..18896060 [GRCh38] Chr19:19006868..19006869 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.274C>T (p.Gln92Ter) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000785041] |
Chr19:18893551 [GRCh38] Chr19:19004360 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.248G>A (p.Arg83Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000986207] |
Chr19:18895825 [GRCh38] Chr19:19006634 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.575C>T (p.Ser192Phe) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000812549] |
Chr19:18884102 [GRCh38] Chr19:18994911 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.989G>T (p.Ser330Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000795450] |
Chr19:18878951 [GRCh38] Chr19:18989760 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1030C>T (p.Pro344Ser) |
single nucleotide variant |
not provided [RCV002534908] |
Chr19:18868686 [GRCh38] Chr19:18979495 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.250C>A (p.Pro84Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000797753]|not specified [RCV004897655] |
Chr19:18893575 [GRCh38] Chr19:19004384 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.763C>T (p.Arg255Cys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000986205] |
Chr19:18879378 [GRCh38] Chr19:18990187 [GRCh37] Chr19:19p13.11 |
likely pathogenic|conflicting interpretations of pathogenicity |
NM_001492.6(GDF1):c.367C>T (p.His123Tyr) |
single nucleotide variant |
not provided [RCV001090559] |
Chr19:18869349 [GRCh38] Chr19:18980158 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.493G>A (p.Ala165Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000810734]|not specified [RCV004609540] |
Chr19:18884184 [GRCh38] Chr19:18994993 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1075C>T (p.Arg359Trp) |
single nucleotide variant |
not provided [RCV002537431] |
Chr19:18868641 [GRCh38] Chr19:18979450 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.523_586dup (p.Ala196fs) |
duplication |
Visceral heterotaxy [RCV000824223] |
Chr19:18869129..18869130 [GRCh38] Chr19:18979938..18979939 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_001492.6(GDF1):c.185T>C (p.Met62Thr) |
single nucleotide variant |
not provided [RCV002536015] |
Chr19:18870123 [GRCh38] Chr19:18980932 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.244T>C (p.Phe82Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000806856] |
Chr19:18895829 [GRCh38] Chr19:19006638 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.701G>A (p.Arg234Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001067509]|not specified [RCV004030653] |
Chr19:18880325 [GRCh38] Chr19:18991134 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.590+3A>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001202468] |
Chr19:18884084 [GRCh38] Chr19:18994893 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.812G>C (p.Arg271Pro) |
single nucleotide variant |
not provided [RCV002568543] |
Chr19:18868904 [GRCh38] Chr19:18979713 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.443T>C (p.Ile148Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001242228]|not specified [RCV004609700] |
Chr19:18884234 [GRCh38] Chr19:18995043 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.177G>C (p.Glu59Asp) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001222207] |
Chr19:18895896 [GRCh38] Chr19:19006705 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.903C>A (p.Tyr301Ter) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001229311] |
Chr19:18879037 [GRCh38] Chr19:18989846 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.772G>A (p.Val258Met) |
single nucleotide variant |
not specified [RCV004312945] |
Chr19:18868944 [GRCh38] Chr19:18979753 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.436C>T (p.Arg146Trp) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001245814] |
Chr19:18884241 [GRCh38] Chr19:18995050 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.637C>T (p.Leu213Phe) |
single nucleotide variant |
not provided [RCV003104857] |
Chr19:18869079 [GRCh38] Chr19:18979888 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.586G>A (p.Ala196Thr) |
single nucleotide variant |
not provided [RCV003231924] |
Chr19:18869130 [GRCh38] Chr19:18979939 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.570C>T (p.Ile190=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001415759] |
Chr19:18884107 [GRCh38] Chr19:18994916 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.174C>G (p.Pro58=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000954383] |
Chr19:18895899 [GRCh38] Chr19:19006708 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.306C>T (p.Ser102=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000914753] |
Chr19:18893519 [GRCh38] Chr19:19004328 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.252C>T (p.Pro84=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001453438] |
Chr19:18893573 [GRCh38] Chr19:19004382 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.498G>A (p.Thr166=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001394496] |
Chr19:18884179 [GRCh38] Chr19:18994988 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.50C>T (p.Pro17Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001236108] |
Chr19:18896023 [GRCh38] Chr19:19006832 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.293A>G (p.Lys98Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001220173]|not specified [RCV004609673] |
Chr19:18893532 [GRCh38] Chr19:19004341 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.219_220insGGCTGGACCGCGCTG (p.Leu73_Arg74insGlyTrpThrAlaLeu) |
insertion |
Progressive myoclonic epilepsy type 8 [RCV001218296] |
Chr19:18895853..18895854 [GRCh38] Chr19:19006662..19006663 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.900+8G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001501800] |
Chr19:18879233 [GRCh38] Chr19:18990042 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.417G>A (p.Thr139=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV000935788] |
Chr19:18884260 [GRCh38] Chr19:18995069 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.289del (p.Val97fs) |
deletion |
not provided [RCV002553346] |
Chr19:18870019 [GRCh38] Chr19:18980828 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_001492.6(GDF1):c.891G>C (p.Gln297His) |
single nucleotide variant |
not provided [RCV001723267] |
Chr19:18868825 [GRCh38] Chr19:18979634 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.469_470insGCG (p.Ala156_Ala157insGly) |
insertion |
not provided [RCV001675100] |
Chr19:18869246..18869247 [GRCh38] Chr19:18980055..18980056 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.380G>A (p.Trp127Ter) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV001254622] |
Chr19:18869336 [GRCh38] Chr19:18980145 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.667dup (p.Ala223fs) |
duplication |
not provided [RCV001169847] |
Chr19:18869048..18869049 [GRCh38] Chr19:18979857..18979858 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.289G>A (p.Ala97Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001049207] |
Chr19:18893536 [GRCh38] Chr19:19004345 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.*151G>T |
single nucleotide variant |
not provided [RCV001541643] |
Chr19:18870426 [GRCh38] Chr19:18981235 [GRCh37] Chr19:19p13.11 |
benign |
NM_001492.6(GDF1):c.196T>C (p.Phe66Leu) |
single nucleotide variant |
not provided [RCV002555868] |
Chr19:18870112 [GRCh38] Chr19:18980921 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.591-3C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001060385] |
Chr19:18880438 [GRCh38] Chr19:18991247 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.95C>T (p.Ala32Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001235965] |
Chr19:18895978 [GRCh38] Chr19:19006787 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.945C>G (p.His315Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001213697] |
Chr19:18878995 [GRCh38] Chr19:18989804 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.527C>G (p.Ser176Trp) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001057981]|not provided [RCV001507432] |
Chr19:18884150 [GRCh38] Chr19:18994959 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1028C>G (p.Ser343Trp) |
single nucleotide variant |
not provided [RCV002563787] |
Chr19:18868688 [GRCh38] Chr19:18979497 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.779C>T (p.Pro260Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001213402] |
Chr19:18879362 [GRCh38] Chr19:18990171 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.458C>T (p.Ala153Val) |
single nucleotide variant |
not provided [RCV002553053] |
Chr19:18869258 [GRCh38] Chr19:18980067 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.683G>A (p.Arg228His) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001213250] |
Chr19:18880343 [GRCh38] Chr19:18991152 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.476A>G (p.Tyr159Cys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001042103] |
Chr19:18884201 [GRCh38] Chr19:18995010 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.787_814del (p.Pro263fs) |
deletion |
Inborn genetic diseases [RCV001266089] |
Chr19:18868902..18868929 [GRCh38] Chr19:18979711..18979738 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.608G>A (p.Trp203Ter) |
single nucleotide variant |
Heterotaxy [RCV001732105]|Inborn genetic diseases [RCV001266629]|not provided [RCV001724281] |
Chr19:18869108 [GRCh38] Chr19:18979917 [GRCh37] Chr19:19p13.11 |
pathogenic|likely pathogenic |
GRCh37/hg19 19p13.12-12(chr19:14286624-20956753)x3 |
copy number gain |
not provided [RCV001259370] |
Chr19:14286624..20956753 [GRCh37] Chr19:19p13.12-12 |
pathogenic |
NM_001492.6(GDF1):c.1040_1051dup (p.Phe350_Asp351insValLeuPhePhe) |
duplication |
not provided [RCV002541824] |
Chr19:18868664..18868665 [GRCh38] Chr19:18979473..18979474 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.767A>G (p.Glu256Gly) |
single nucleotide variant |
not provided [RCV002547493] |
Chr19:18868949 [GRCh38] Chr19:18979758 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.315C>G (p.Ile105Met) |
single nucleotide variant |
not provided [RCV002551063] |
Chr19:18869993 [GRCh38] Chr19:18980802 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.701G>T (p.Arg234Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001307385] |
Chr19:18880325 [GRCh38] Chr19:18991134 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.550G>A (p.Val184Met) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001316843] |
Chr19:18884127 [GRCh38] Chr19:18994936 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.18_29dup (p.Pro10_Thr11insAlaAlaGlyPro) |
duplication |
Progressive myoclonic epilepsy type 8 [RCV001317135] |
Chr19:18896043..18896044 [GRCh38] Chr19:19006852..19006853 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.610C>G (p.Leu204Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001341798] |
Chr19:18880416 [GRCh38] Chr19:18991225 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.821C>T (p.Thr274Met) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001339481]|not specified [RCV004035900] |
Chr19:18879320 [GRCh38] Chr19:18990129 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.818G>A (p.Arg273His) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001316735] |
Chr19:18879323 [GRCh38] Chr19:18990132 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.835C>G (p.Pro279Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001327621] |
Chr19:18879306 [GRCh38] Chr19:18990115 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.962G>A (p.Arg321Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001338944] |
Chr19:18878978 [GRCh38] Chr19:18989787 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.87C>G (p.Ser29Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001296958] |
Chr19:18895986 [GRCh38] Chr19:19006795 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.649C>G (p.Leu217Val) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV001332016]|not provided [RCV002543239] |
Chr19:18869067 [GRCh38] Chr19:18979876 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.173C>T (p.Pro58Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001325875] |
Chr19:18895900 [GRCh38] Chr19:19006709 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.830G>A (p.Arg277His) |
single nucleotide variant |
not provided [RCV002538490] |
Chr19:18868886 [GRCh38] Chr19:18979695 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.688G>A (p.Gly230Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001327025] |
Chr19:18880338 [GRCh38] Chr19:18991147 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.12G>A (p.Ala4=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001396658] |
Chr19:18896061 [GRCh38] Chr19:19006870 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.511A>G (p.Thr171Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001370511] |
Chr19:18884166 [GRCh38] Chr19:18994975 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.873C>G (p.Leu291=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001432986] |
Chr19:18879268 [GRCh38] Chr19:18990077 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.997G>A (p.Asp333Asn) |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV001333949] |
Chr19:18868719 [GRCh38] Chr19:18979528 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.71_72delinsCC (p.Gln24Pro) |
indel |
Progressive myoclonic epilepsy type 8 [RCV001362273] |
Chr19:18896001..18896002 [GRCh38] Chr19:19006810..19006811 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.689G>C (p.Gly230Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001320010] |
Chr19:18880337 [GRCh38] Chr19:18991146 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.236G>A (p.Arg79Gln) |
single nucleotide variant |
not provided [RCV002547041] |
Chr19:18870072 [GRCh38] Chr19:18980881 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.74G>A (p.Arg25His) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001343651] |
Chr19:18895999 [GRCh38] Chr19:19006808 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NC_000019.9:g.(?_19004205)_(19006901_?)dup |
duplication |
Progressive myoclonic epilepsy type 8 [RCV001323937] |
Chr19:19004205..19006901 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.608T>C (p.Ile203Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001317783] |
Chr19:18880418 [GRCh38] Chr19:18991227 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.738C>G (p.Ser246Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001324303] |
Chr19:18880288 [GRCh38] Chr19:18991097 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.62_73del (p.Leu21_Leu24del) |
deletion |
not provided [RCV002547785] |
Chr19:18870235..18870246 [GRCh38] Chr19:18981044..18981055 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.-3A>C |
single nucleotide variant |
not provided [RCV001311506] |
Chr19:18870310 [GRCh38] Chr19:18981119 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.89C>T (p.Ala30Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001322709] |
Chr19:18895984 [GRCh38] Chr19:19006793 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1102G>A (p.Glu368Lys) |
single nucleotide variant |
not provided [RCV002539544]|not specified [RCV004036301] |
Chr19:18868614 [GRCh38] Chr19:18979423 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.709G>A (p.Ala237Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001350884] |
Chr19:18880317 [GRCh38] Chr19:18991126 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.102_103insTCG (p.Ala34_Arg35insSer) |
insertion |
Progressive myoclonic epilepsy type 8 [RCV001359310] |
Chr19:18895970..18895971 [GRCh38] Chr19:19006779..19006780 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.297A>G (p.Gly99=) |
single nucleotide variant |
not provided [RCV002563297] |
Chr19:18870011 [GRCh38] Chr19:18980820 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.942G>A (p.Val314=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001495310] |
Chr19:18878998 [GRCh38] Chr19:18989807 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.412C>A (p.Pro138Thr) |
single nucleotide variant |
not provided [RCV002555125]|not specified [RCV004038220] |
Chr19:18869304 [GRCh38] Chr19:18980113 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.393A>G (p.Pro131=) |
single nucleotide variant |
CERS1-related disorder [RCV003948424]|Progressive myoclonic epilepsy type 8 [RCV001487604] |
Chr19:18893432 [GRCh38] Chr19:19004241 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.528G>A (p.Ser176=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001473393] |
Chr19:18884149 [GRCh38] Chr19:18994958 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.742dup (p.Leu248fs) |
duplication |
not provided [RCV002551561] |
Chr19:18868973..18868974 [GRCh38] Chr19:18979782..18979783 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.750C>T (p.Ser250=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001496873] |
Chr19:18880276 [GRCh38] Chr19:18991085 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.540G>T (p.Leu180=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001431141] |
Chr19:18884137 [GRCh38] Chr19:18994946 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.958C>T (p.Leu320=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001503467] |
Chr19:18878982 [GRCh38] Chr19:18989791 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.54C>T (p.Ala18=) |
single nucleotide variant |
not provided [RCV002555139] |
Chr19:18870254 [GRCh38] Chr19:18981063 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.519C>A (p.Arg173=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001487558] |
Chr19:18884158 [GRCh38] Chr19:18994967 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1011-4C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001493153] |
Chr19:18870623 [GRCh38] Chr19:18981432 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1035G>A (p.Val345=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001487952] |
Chr19:18870595 [GRCh38] Chr19:18981404 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.429A>C (p.Ala143=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001493497]|not provided [RCV003405688] |
Chr19:18884248 [GRCh38] Chr19:18995057 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.903G>A (p.Ala301=) |
single nucleotide variant |
not provided [RCV002559334] |
Chr19:18868813 [GRCh38] Chr19:18979622 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.741C>T (p.Pro247=) |
single nucleotide variant |
not provided [RCV002555530] |
Chr19:18868975 [GRCh38] Chr19:18979784 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1032G>A (p.Leu344=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001449244] |
Chr19:18870598 [GRCh38] Chr19:18981407 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.531G>A (p.Val177=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001419183] |
Chr19:18884146 [GRCh38] Chr19:18994955 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.702G>A (p.Arg234=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001445114] |
Chr19:18880324 [GRCh38] Chr19:18991133 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.18C>G (p.Pro6=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001404309] |
Chr19:18896055 [GRCh38] Chr19:19006864 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.591-6C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001486635] |
Chr19:18880441 [GRCh38] Chr19:18991250 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.273C>G (p.Leu91=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001455240] |
Chr19:18893552 [GRCh38] Chr19:19004361 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.901-4G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001466354] |
Chr19:18879043 [GRCh38] Chr19:18989852 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.627C>T (p.His209=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001470681] |
Chr19:18880399 [GRCh38] Chr19:18991208 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.468G>A (p.Ala156=) |
single nucleotide variant |
not provided [RCV002562693] |
Chr19:18869248 [GRCh38] Chr19:18980057 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.684C>T (p.Arg228=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001401173] |
Chr19:18880342 [GRCh38] Chr19:18991151 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.45C>T (p.Pro15=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001468896] |
Chr19:18896028 [GRCh38] Chr19:19006837 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.567C>T (p.Leu189=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001468653] |
Chr19:18884110 [GRCh38] Chr19:18994919 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.264G>C (p.Arg88=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001458455] |
Chr19:18893561 [GRCh38] Chr19:19004370 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.78G>C (p.Leu26=) |
single nucleotide variant |
GDF1-related disorder [RCV003938732]|not provided [RCV002555119] |
Chr19:18870230 [GRCh38] Chr19:18981039 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.889C>T (p.Gln297Ter) |
single nucleotide variant |
not provided [RCV002551545] |
Chr19:18868827 [GRCh38] Chr19:18979636 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.432G>A (p.Val144=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001503956] |
Chr19:18884245 [GRCh38] Chr19:18995054 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1104G>A (p.Glu368=) |
single nucleotide variant |
not provided [RCV002551610] |
Chr19:18868612 [GRCh38] Chr19:18979421 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1041G>T (p.Val347=) |
single nucleotide variant |
GDF1-related disorder [RCV003938681]|not provided [RCV002553396] |
Chr19:18868675 [GRCh38] Chr19:18979484 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.*1120G>A |
single nucleotide variant |
Congenital heart defects, multiple types, 6 [RCV001733713] |
Chr19:18868865 [GRCh38] Chr19:18979674 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.686G>C (p.Arg229Pro) |
single nucleotide variant |
not provided [RCV001771370] |
Chr19:18869030 [GRCh38] Chr19:18979839 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.84_91del (p.Val31fs) |
deletion |
not provided [RCV001786933] |
Chr19:18870217..18870224 [GRCh38] Chr19:18981026..18981033 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.339G>T (p.Arg113=) |
single nucleotide variant |
not provided [RCV001815853] |
Chr19:18869377 [GRCh38] Chr19:18980186 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.182T>C (p.Leu61Pro) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001896197] |
Chr19:18895891 [GRCh38] Chr19:19006700 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.476C>T (p.Pro159Leu) |
single nucleotide variant |
not provided [RCV002573385] |
Chr19:18869240 [GRCh38] Chr19:18980049 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.262C>T (p.Arg88Trp) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002025035] |
Chr19:18893563 [GRCh38] Chr19:19004372 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.158C>T (p.Ala53Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002025800] |
Chr19:18895915 [GRCh38] Chr19:19006724 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.596T>C (p.Leu199Pro) |
single nucleotide variant |
Right atrial isomerism [RCV002503359]|not provided [RCV002545361] |
Chr19:18869120 [GRCh38] Chr19:18979929 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.698A>G (p.His233Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002025162] |
Chr19:18880328 [GRCh38] Chr19:18991137 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.700C>G (p.Arg234Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001864609] |
Chr19:18880326 [GRCh38] Chr19:18991135 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.835C>A (p.Pro279Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001982804]|not specified [RCV004043715] |
Chr19:18879306 [GRCh38] Chr19:18990115 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.264dup (p.Pro89fs) |
duplication |
not provided [RCV001783358] |
Chr19:18870043..18870044 [GRCh38] Chr19:18980852..18980853 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.305G>A (p.Ser102Asn) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002003202] |
Chr19:18893520 [GRCh38] Chr19:19004329 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.579_678del (p.Val194fs) |
deletion |
not provided [RCV001782181] |
Chr19:18869038..18869137 [GRCh38] Chr19:18979847..18979946 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_021267.5(CERS1):c.312del (p.Ala103_Trp104insTer) |
deletion |
Progressive myoclonic epilepsy type 8 [RCV002041401] |
Chr19:18893513 [GRCh38] Chr19:19004322 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.30_38del (p.Thr11_Pro13del) |
deletion |
Progressive myoclonic epilepsy type 8 [RCV001895624] |
Chr19:18896035..18896043 [GRCh38] Chr19:19006844..19006852 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1016C>A (p.Pro339His) |
single nucleotide variant |
not provided [RCV002552322] |
Chr19:18868700 [GRCh38] Chr19:18979509 [GRCh37] Chr19:19p13.11 |
uncertain significance |
CERS1, ARG255CYS |
variation |
Progressive myoclonic epilepsy type 8 [RCV001849244] |
|
pathogenic |
NM_021267.5(CERS1):c.319C>G (p.Leu107Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001967896] |
Chr19:18893506 [GRCh38] Chr19:19004315 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.470G>A (p.Ser157Asn) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002044441] |
Chr19:18884207 [GRCh38] Chr19:18995016 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.900C>T (p.Cys300=) |
single nucleotide variant |
not provided [RCV002555791] |
Chr19:18868816 [GRCh38] Chr19:18979625 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_001492.6(GDF1):c.796G>A (p.Ala266Thr) |
single nucleotide variant |
not provided [RCV002554160]|not specified [RCV003331223] |
Chr19:18868920 [GRCh38] Chr19:18979729 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.709G>T (p.Ala237Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001871271] |
Chr19:18880317 [GRCh38] Chr19:18991126 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.974C>T (p.Thr325Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001969726] |
Chr19:18878966 [GRCh38] Chr19:18989775 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1009G>C (p.Glu337Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001985618] |
Chr19:18878931 [GRCh38] Chr19:18989740 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.725T>C (p.Leu242Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002006478] |
Chr19:18880301 [GRCh38] Chr19:18991110 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.845T>A (p.Phe282Tyr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001908695]|not specified [RCV004042549] |
Chr19:18879296 [GRCh38] Chr19:18990105 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.408C>T (p.Tyr136=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001884137] |
Chr19:18893417 [GRCh38] Chr19:19004226 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.626G>A (p.Trp209Ter) |
single nucleotide variant |
not provided [RCV002563633] |
Chr19:18869090 [GRCh38] Chr19:18979899 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_001492.6(GDF1):c.765C>A (p.Ala255=) |
single nucleotide variant |
not provided [RCV002564448] |
Chr19:18868951 [GRCh38] Chr19:18979760 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.1030C>G (p.Leu344Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001962254] |
Chr19:18870600 [GRCh38] Chr19:18981409 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.911C>T (p.Ala304Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001925174]|not specified [RCV004611971] |
Chr19:18879029 [GRCh38] Chr19:18989838 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.251G>A (p.Gly84Glu) |
single nucleotide variant |
not provided [RCV002579564] |
Chr19:18870057 [GRCh38] Chr19:18980866 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.410-20_410-19del |
microsatellite |
Progressive myoclonic epilepsy type 8 [RCV001963213] |
Chr19:18884286..18884287 [GRCh38] Chr19:18995095..18995096 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.18_29del (p.3AAGP[1]) |
deletion |
Progressive myoclonic epilepsy type 8 [RCV002038779] |
Chr19:18896044..18896055 [GRCh38] Chr19:19006853..19006864 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.817C>T (p.Arg273Cys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001998945] |
Chr19:18879324 [GRCh38] Chr19:18990133 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.349G>T (p.Ala117Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002029206]|not specified [RCV004046801] |
Chr19:18893476 [GRCh38] Chr19:19004285 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.440A>G (p.Asp147Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001991069] |
Chr19:18884237 [GRCh38] Chr19:18995046 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NC_000019.9:g.(?_18893725)_(19312528_?)del |
deletion |
Progressive myoclonic epilepsy type 8 [RCV001955725] |
Chr19:18893725..19312528 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.465G>A (p.Ala155=) |
single nucleotide variant |
not provided [RCV002571377] |
Chr19:18869251 [GRCh38] Chr19:18980060 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.797C>T (p.Ala266Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001935845]|not specified [RCV004897701] |
Chr19:18879344 [GRCh38] Chr19:18990153 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.571G>A (p.Val191Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001931350]|not provided [RCV002511116] |
Chr19:18884106 [GRCh38] Chr19:18994915 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.46A>G (p.Met16Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002049611] |
Chr19:18896027 [GRCh38] Chr19:19006836 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.715_716delinsTT (p.Ala239Leu) |
indel |
Progressive myoclonic epilepsy type 8 [RCV001902168] |
Chr19:18880310..18880311 [GRCh38] Chr19:18991119..18991120 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.350C>T (p.Ala117Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002046017] |
Chr19:18893475 [GRCh38] Chr19:19004284 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1092G>A (p.Met364Ile) |
single nucleotide variant |
not provided [RCV002545522] |
Chr19:18868624 [GRCh38] Chr19:18979433 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_021267.5(CERS1):c.572T>C (p.Val191Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001918547] |
Chr19:18884105 [GRCh38] Chr19:18994914 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.307G>T (p.Ala103Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002027844] |
Chr19:18893518 [GRCh38] Chr19:19004327 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.785A>G (p.Lys262Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001866831] |
Chr19:18879356 [GRCh38] Chr19:18990165 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.961C>T (p.Arg321Trp) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001866961] |
Chr19:18878979 [GRCh38] Chr19:18989788 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.82G>A (p.Gly28Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002017006]|not specified [RCV004897729] |
Chr19:18895991 [GRCh38] Chr19:19006800 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.590G>A (p.Arg197Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001916452] |
Chr19:18884087 [GRCh38] Chr19:18994896 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.955G>A (p.Asp319Asn) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001957788] |
Chr19:18878985 [GRCh38] Chr19:18989794 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.682C>T (p.Arg228Cys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001900726]|not specified [RCV004040640] |
Chr19:18880344 [GRCh38] Chr19:18991153 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.68T>C (p.Val23Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001961113] |
Chr19:18896005 [GRCh38] Chr19:19006814 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.211A>G (p.Thr71Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001980244] |
Chr19:18895862 [GRCh38] Chr19:19006671 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.637G>A (p.Asp213Asn) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002011132] |
Chr19:18880389 [GRCh38] Chr19:18991198 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.263G>A (p.Arg88Gln) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002029514] |
Chr19:18893562 [GRCh38] Chr19:19004371 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.356C>T (p.Ser119Leu) |
single nucleotide variant |
not provided [RCV002473328] |
Chr19:18869360 [GRCh38] Chr19:18980169 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.830A>C (p.Asp277Ala) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001884064] |
Chr19:18879311 [GRCh38] Chr19:18990120 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.410-6C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001998565] |
Chr19:18884273 [GRCh38] Chr19:18995082 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.123C>G (p.Gly41=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001926028] |
Chr19:18895950 [GRCh38] Chr19:19006759 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_001492.6(GDF1):c.1019C>G (p.Ala340Gly) |
single nucleotide variant |
not provided [RCV002545578] |
Chr19:18868697 [GRCh38] Chr19:18979506 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.133G>C (p.Ala45Pro) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001881918]|not specified [RCV004611959] |
Chr19:18895940 [GRCh38] Chr19:19006749 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.901-6T>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002010040] |
Chr19:18879045 [GRCh38] Chr19:18989854 [GRCh37] Chr19:19p13.11 |
likely benign|uncertain significance |
NM_021267.5(CERS1):c.158C>G (p.Ala53Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001978347] |
Chr19:18895915 [GRCh38] Chr19:19006724 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.505A>G (p.Met169Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV001916465] |
Chr19:18884172 [GRCh38] Chr19:18994981 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.780G>T (p.Pro260=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002109863] |
Chr19:18879361 [GRCh38] Chr19:18990170 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.66A>C (p.Leu22=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002074710] |
Chr19:18896007 [GRCh38] Chr19:19006816 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.732C>T (p.Cys244=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002104668] |
Chr19:18880294 [GRCh38] Chr19:18991103 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1011-8del |
deletion |
Progressive myoclonic epilepsy type 8 [RCV002129037] |
Chr19:18870627 [GRCh38] Chr19:18981436 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.591-15C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002111485] |
Chr19:18880450 [GRCh38] Chr19:18991259 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.717A>G (p.Ala239=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002108622] |
Chr19:18880309 [GRCh38] Chr19:18991118 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.387T>C (p.His129=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002085718] |
Chr19:18893438 [GRCh38] Chr19:19004247 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.9G>A (p.Ala3=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002112248] |
Chr19:18896064 [GRCh38] Chr19:19006873 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.366G>A (p.Gly122=) |
single nucleotide variant |
not provided [RCV003007024] |
Chr19:18869350 [GRCh38] Chr19:18980159 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.798C>T (p.Ala266=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002204916] |
Chr19:18879343 [GRCh38] Chr19:18990152 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.590+15G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002150753] |
Chr19:18884072 [GRCh38] Chr19:18994881 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.294G>A (p.Lys98=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002112983]|not provided [RCV004704746] |
Chr19:18893531 [GRCh38] Chr19:19004340 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.549C>T (p.His183=) |
single nucleotide variant |
CERS1-related disorder [RCV003960936]|Progressive myoclonic epilepsy type 8 [RCV002206475] |
Chr19:18884128 [GRCh38] Chr19:18994937 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.816G>A (p.Leu272=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002190117] |
Chr19:18879325 [GRCh38] Chr19:18990134 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.402C>A (p.Val134=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002172758] |
Chr19:18893423 [GRCh38] Chr19:19004232 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.768C>A (p.Leu256=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002112853] |
Chr19:18879373 [GRCh38] Chr19:18990182 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.409+7G>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002169998] |
Chr19:18893409 [GRCh38] Chr19:19004218 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.780G>A (p.Pro260=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002077010] |
Chr19:18879361 [GRCh38] Chr19:18990170 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1010+19G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002095839] |
Chr19:18878911 [GRCh38] Chr19:18989720 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.790C>T (p.Leu264=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002071371] |
Chr19:18879351 [GRCh38] Chr19:18990160 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.591-15C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002171541] |
Chr19:18880450 [GRCh38] Chr19:18991259 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1008C>T (p.Ala336=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002206065] |
Chr19:18878932 [GRCh38] Chr19:18989741 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.990C>T (p.Ser330=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002101477] |
Chr19:18878950 [GRCh38] Chr19:18989759 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.945C>T (p.His315=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002217191] |
Chr19:18878995 [GRCh38] Chr19:18989804 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1010+18C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002102529] |
Chr19:18878912 [GRCh38] Chr19:18989721 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.558T>C (p.Thr186=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002160244] |
Chr19:18884119 [GRCh38] Chr19:18994928 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.978C>A (p.Ala326=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002217432] |
Chr19:18878962 [GRCh38] Chr19:18989771 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.369C>T (p.Thr123=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002217932] |
Chr19:18893456 [GRCh38] Chr19:19004265 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.999C>T (p.Pro333=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002177064] |
Chr19:18878941 [GRCh38] Chr19:18989750 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.410-17G>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002204168] |
Chr19:18884284 [GRCh38] Chr19:18995093 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1011-16C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002175972] |
Chr19:18870635 [GRCh38] Chr19:18981444 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.*773G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002219126] |
Chr19:18869212 [GRCh38] Chr19:18980021 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.180G>A (p.Leu60=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002103456] |
Chr19:18895893 [GRCh38] Chr19:19006702 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.171G>T (p.Pro57=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002159235] |
Chr19:18895902 [GRCh38] Chr19:19006711 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.590+14C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002200798] |
Chr19:18884073 [GRCh38] Chr19:18994882 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.156C>T (p.His52=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002161650] |
Chr19:18895917 [GRCh38] Chr19:19006726 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.420G>C (p.Pro140=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002098224] |
Chr19:18884257 [GRCh38] Chr19:18995066 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.900+20C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002162987] |
Chr19:18879221 [GRCh38] Chr19:18990030 [GRCh37] Chr19:19p13.11 |
likely benign |
NC_000019.9:g.(?_17927663)_(19312528_?)dup |
duplication |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 [RCV003116292] |
Chr19:17927663..19312528 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.91_98dup (p.Gly34fs) |
duplication |
Right atrial isomerism [RCV004789876] |
Chr19:18870209..18870210 [GRCh38] Chr19:18981018..18981019 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.418G>C (p.Glu140Gln) |
single nucleotide variant |
not provided [RCV003154526] |
Chr19:18869298 [GRCh38] Chr19:18980107 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.176C>T (p.Pro59Leu) |
single nucleotide variant |
not provided [RCV002308845] |
Chr19:18870132 [GRCh38] Chr19:18980941 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.113C>A (p.Thr38Lys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002974819] |
Chr19:18895960 [GRCh38] Chr19:19006769 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.149A>G (p.Gln50Arg) |
single nucleotide variant |
not specified [RCV004108524] |
Chr19:18870159 [GRCh38] Chr19:18980968 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.198C>G (p.Gly66=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003075029] |
Chr19:18895875 [GRCh38] Chr19:19006684 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.653C>A (p.Ala218Glu) |
single nucleotide variant |
not provided [RCV002775407] |
Chr19:18869063 [GRCh38] Chr19:18979872 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.840C>T (p.Phe280=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002995799] |
Chr19:18879301 [GRCh38] Chr19:18990110 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.102G>C (p.Ala34=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002904940] |
Chr19:18895971 [GRCh38] Chr19:19006780 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.590+11G>C |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002882279] |
Chr19:18884076 [GRCh38] Chr19:18994885 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.431G>C (p.Arg144Pro) |
single nucleotide variant |
not provided [RCV002904627] |
Chr19:18869285 [GRCh38] Chr19:18980094 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.977C>G (p.Ala326Gly) |
single nucleotide variant |
not specified [RCV004127165] |
Chr19:18868739 [GRCh38] Chr19:18979548 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1096G>T (p.Val366Leu) |
single nucleotide variant |
not specified [RCV004120106] |
Chr19:18868620 [GRCh38] Chr19:18979429 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.809G>A (p.Cys270Tyr) |
single nucleotide variant |
not specified [RCV004245226] |
Chr19:18879332 [GRCh38] Chr19:18990141 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.68T>G (p.Val23Gly) |
single nucleotide variant |
not specified [RCV004166587] |
Chr19:18896005 [GRCh38] Chr19:19006814 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1095G>A (p.Val365=) |
single nucleotide variant |
not provided [RCV002760231] |
Chr19:18868621 [GRCh38] Chr19:18979430 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.307G>A (p.Ala103Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002871392] |
Chr19:18893518 [GRCh38] Chr19:19004327 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.81G>C (p.Trp27Cys) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002696049] |
Chr19:18895992 [GRCh38] Chr19:19006801 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.878C>T (p.Ala293Val) |
single nucleotide variant |
GDF1-related disorder [RCV003420521]|not specified [RCV004230851] |
Chr19:18868838 [GRCh38] Chr19:18979647 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.72G>C (p.Gln24His) |
single nucleotide variant |
not specified [RCV004242177] |
Chr19:18896001 [GRCh38] Chr19:19006810 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.39C>G (p.Pro13=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002638411] |
Chr19:18896034 [GRCh38] Chr19:19006843 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.900+11C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003002732] |
Chr19:18879230 [GRCh38] Chr19:18990039 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.591-8T>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003020636] |
Chr19:18880443 [GRCh38] Chr19:18991252 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.220C>A (p.Arg74Ser) |
single nucleotide variant |
not specified [RCV004113017] |
Chr19:18895853 [GRCh38] Chr19:19006662 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.951G>A (p.Leu317=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002638597] |
Chr19:18878989 [GRCh38] Chr19:18989798 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.69G>T (p.Ser23=) |
single nucleotide variant |
not provided [RCV002886391] |
Chr19:18870239 [GRCh38] Chr19:18981048 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.71A>C (p.Gln24Pro) |
single nucleotide variant |
not specified [RCV004242176] |
Chr19:18896002 [GRCh38] Chr19:19006811 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.192G>T (p.Ala64=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002659672] |
Chr19:18895881 [GRCh38] Chr19:19006690 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.38T>A (p.Leu13His) |
single nucleotide variant |
not provided [RCV002978970] |
Chr19:18870270 [GRCh38] Chr19:18981079 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.250-20G>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003008309] |
Chr19:18893595 [GRCh38] Chr19:19004404 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.512C>T (p.Thr171Ile) |
single nucleotide variant |
not specified [RCV004143907] |
Chr19:18884165 [GRCh38] Chr19:18994974 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1016C>T (p.Pro339Leu) |
single nucleotide variant |
not specified [RCV004155185] |
Chr19:18868700 [GRCh38] Chr19:18979509 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.761A>C (p.Asp254Ala) |
single nucleotide variant |
not specified [RCV004091692] |
Chr19:18868955 [GRCh38] Chr19:18979764 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.195C>T (p.Leu65=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003082219] |
Chr19:18895878 [GRCh38] Chr19:19006687 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.517G>A (p.Gly173Ser) |
single nucleotide variant |
not provided [RCV003041593] |
Chr19:18869199 [GRCh38] Chr19:18980008 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.518G>A (p.Arg173His) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003083705] |
Chr19:18884159 [GRCh38] Chr19:18994968 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.148G>T (p.Ala50Ser) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002875690] |
Chr19:18895925 [GRCh38] Chr19:19006734 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.420G>A (p.Pro140=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002932637] |
Chr19:18884257 [GRCh38] Chr19:18995066 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.738C>T (p.His246=) |
single nucleotide variant |
not provided [RCV003022853] |
Chr19:18868978 [GRCh38] Chr19:18979787 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.846C>T (p.Phe282=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002624809] |
Chr19:18879295 [GRCh38] Chr19:18990104 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.634A>G (p.Ser212Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003007998] |
Chr19:18880392 [GRCh38] Chr19:18991201 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.591-3del |
deletion |
Progressive myoclonic epilepsy type 8 [RCV002872758] |
Chr19:18880438 [GRCh38] Chr19:18991247 [GRCh37] Chr19:19p13.11 |
benign |
NM_021267.5(CERS1):c.591-10G>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002985541] |
Chr19:18880445 [GRCh38] Chr19:18991254 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.611T>A (p.Leu204His) |
single nucleotide variant |
not specified [RCV004169279] |
Chr19:18880415 [GRCh38] Chr19:18991224 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.753-4G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002720652] |
Chr19:18879392 [GRCh38] Chr19:18990201 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.984C>G (p.Ala328=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003010179] |
Chr19:18878956 [GRCh38] Chr19:18989765 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.805C>T (p.His269Tyr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002598172] |
Chr19:18879336 [GRCh38] Chr19:18990145 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.37C>A (p.Pro13Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003061339] |
Chr19:18896036 [GRCh38] Chr19:19006845 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.586T>A (p.Phe196Ile) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003046453] |
Chr19:18884091 [GRCh38] Chr19:18994900 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.15G>T (p.Gly5=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002933943] |
Chr19:18896058 [GRCh38] Chr19:19006867 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.900+7C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002599690] |
Chr19:18879234 [GRCh38] Chr19:18990043 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.124T>G (p.Trp42Gly) |
single nucleotide variant |
not specified [RCV004168885] |
Chr19:18895949 [GRCh38] Chr19:19006758 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.587C>G (p.Ala196Gly) |
single nucleotide variant |
not specified [RCV004097298] |
Chr19:18869129 [GRCh38] Chr19:18979938 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.17C>G (p.Pro6Arg) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002580147] |
Chr19:18896056 [GRCh38] Chr19:19006865 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1011-4C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003028382] |
Chr19:18870623 [GRCh38] Chr19:18981432 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.753-3C>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003008365] |
Chr19:18879391 [GRCh38] Chr19:18990200 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.148G>C (p.Ala50Pro) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002601044] |
Chr19:18895925 [GRCh38] Chr19:19006734 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1001T>G (p.Leu334Arg) |
single nucleotide variant |
not specified [RCV004130415] |
Chr19:18868715 [GRCh38] Chr19:18979524 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.249+7G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002647602] |
Chr19:18895817 [GRCh38] Chr19:19006626 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.902A>G (p.Tyr301Cys) |
single nucleotide variant |
not specified [RCV004171023] |
Chr19:18879038 [GRCh38] Chr19:18989847 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.234T>A (p.Thr78=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002814410] |
Chr19:18895839 [GRCh38] Chr19:19006648 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.561G>A (p.Val187=) |
single nucleotide variant |
not provided [RCV002583970] |
Chr19:18869155 [GRCh38] Chr19:18979964 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.325+11C>T |
single nucleotide variant |
not provided [RCV002586730] |
Chr19:18869972 [GRCh38] Chr19:18980781 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.978C>T (p.Ala326=) |
single nucleotide variant |
CERS1-related disorder [RCV003936279]|Progressive myoclonic epilepsy type 8 [RCV002604032] |
Chr19:18878962 [GRCh38] Chr19:18989771 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.667A>G (p.Ile223Val) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003071036] |
Chr19:18880359 [GRCh38] Chr19:18991168 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.987G>A (p.Pro329=) |
single nucleotide variant |
not provided [RCV002586355] |
Chr19:18868729 [GRCh38] Chr19:18979538 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.753-18T>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV002721674] |
Chr19:18879406 [GRCh38] Chr19:18990215 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.250-4A>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003069525] |
Chr19:18893579 [GRCh38] Chr19:19004388 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.661C>G (p.Pro221Ala) |
single nucleotide variant |
not specified [RCV004180558] |
Chr19:18869055 [GRCh38] Chr19:18979864 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.214dup (p.Gln72fs) |
duplication |
not provided [RCV003154548] |
Chr19:18870093..18870094 [GRCh38] Chr19:18980902..18980903 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.144G>T (p.Glu48Asp) |
single nucleotide variant |
not specified [RCV004270358] |
Chr19:18870164 [GRCh38] Chr19:18980973 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.645GGCGCT[1] (p.216AL[1]) |
microsatellite |
not provided [RCV003135351] |
Chr19:18869060..18869065 [GRCh38] Chr19:18979869..18979874 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.572G>C (p.Gly191Ala) |
single nucleotide variant |
not provided [RCV003135352] |
Chr19:18869144 [GRCh38] Chr19:18979953 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.275T>C (p.Val92Ala) |
single nucleotide variant |
not provided [RCV003142555] |
Chr19:18870033 [GRCh38] Chr19:18980842 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.537del (p.Pro180fs) |
deletion |
Congenital heart defects, multiple types, 6 [RCV003322657] |
Chr19:18869179 [GRCh38] Chr19:18979988 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.431G>A (p.Arg144Gln) |
single nucleotide variant |
not provided [RCV003325061] |
Chr19:18869285 [GRCh38] Chr19:18980094 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.575C>T (p.Pro192Leu) |
single nucleotide variant |
not specified [RCV004363436] |
Chr19:18869141 [GRCh38] Chr19:18979950 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.40G>A (p.Glu14Lys) |
single nucleotide variant |
not specified [RCV004345661] |
Chr19:18896033 [GRCh38] Chr19:19006842 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.354C>T (p.Ala118=) |
single nucleotide variant |
not provided [RCV003873259] |
Chr19:18869362 [GRCh38] Chr19:18980171 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.811C>T (p.Arg271Trp) |
single nucleotide variant |
not provided [RCV003487866] |
Chr19:18868905 [GRCh38] Chr19:18979714 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.136C>T (p.Arg46Cys) |
single nucleotide variant |
GDF1-related disorder [RCV003414589] |
Chr19:18870172 [GRCh38] Chr19:18980981 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.620_621delinsTT (p.Ala207Val) |
indel |
GDF1-related disorder [RCV003402256] |
Chr19:18869095..18869096 [GRCh38] Chr19:18979904..18979905 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.934C>G (p.Pro312Ala) |
single nucleotide variant |
GDF1-related disorder [RCV003399783] |
Chr19:18868782 [GRCh38] Chr19:18979591 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.345G>A (p.Ser115=) |
single nucleotide variant |
not provided [RCV003576043] |
Chr19:18869371 [GRCh38] Chr19:18980180 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.834G>A (p.Glu278=) |
single nucleotide variant |
not provided [RCV003662643] |
Chr19:18868882 [GRCh38] Chr19:18979691 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.768_823del (p.Pro257fs) |
deletion |
not specified [RCV003488807] |
Chr19:18868893..18868948 [GRCh38] Chr19:18979702..18979757 [GRCh37] Chr19:19p13.11 |
likely pathogenic |
NM_001492.6(GDF1):c.927C>T (p.Ser309=) |
single nucleotide variant |
not provided [RCV003829177] |
Chr19:18868789 [GRCh38] Chr19:18979598 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.933dup (p.Pro312fs) |
duplication |
not provided [RCV003876851] |
Chr19:18868782..18868783 [GRCh38] Chr19:18979591..18979592 [GRCh37] Chr19:19p13.11 |
pathogenic |
NM_021267.5(CERS1):c.118T>G (p.Cys40Gly) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003824449] |
Chr19:18895955 [GRCh38] Chr19:19006764 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.590+14C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003881402] |
Chr19:18884073 [GRCh38] Chr19:18994882 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.171G>C (p.Pro57=) |
single nucleotide variant |
not provided [RCV003827090] |
Chr19:18870137 [GRCh38] Chr19:18980946 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.1011-5C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751717] |
Chr19:18870624 [GRCh38] Chr19:18981433 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.250-15T>C |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751026] |
Chr19:18893590 [GRCh38] Chr19:19004399 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.940G>T (p.Val314Leu) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751559] |
Chr19:18879000 [GRCh38] Chr19:18989809 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.288C>T (p.Ala96=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751698] |
Chr19:18893537 [GRCh38] Chr19:19004346 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.402C>T (p.Val134=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003750346] |
Chr19:18893423 [GRCh38] Chr19:19004232 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.753-17G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003855863] |
Chr19:18879405 [GRCh38] Chr19:18990214 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.630T>C (p.Asp210=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751474] |
Chr19:18880396 [GRCh38] Chr19:18991205 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.249+19C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003752543] |
Chr19:18895805 [GRCh38] Chr19:19006614 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.506T>C (p.Met169Thr) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751124] |
Chr19:18884171 [GRCh38] Chr19:18994980 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.249+14G>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751603] |
Chr19:18895810 [GRCh38] Chr19:19006619 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.579C>T (p.Ser193=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003751650] |
Chr19:18884098 [GRCh38] Chr19:18994907 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.901-17C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003820665] |
Chr19:18879056 [GRCh38] Chr19:18989865 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.900+13C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003587528] |
Chr19:18879228 [GRCh38] Chr19:18990037 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.864G>A (p.Pro288=) |
single nucleotide variant |
not provided [RCV003707729] |
Chr19:18868852 [GRCh38] Chr19:18979661 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1035C>T (p.Ile345=) |
single nucleotide variant |
not provided [RCV003728892] |
Chr19:18868681 [GRCh38] Chr19:18979490 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.900+14G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003587763] |
Chr19:18879227 [GRCh38] Chr19:18990036 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.594C>T (p.Tyr198=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003586528] |
Chr19:18880432 [GRCh38] Chr19:18991241 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.375C>T (p.Tyr125=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003587862] |
Chr19:18893450 [GRCh38] Chr19:19004259 [GRCh37] Chr19:19p13.11 |
likely benign |
GRCh37/hg19 19p13.11-12(chr19:18926463-21100330)x1 |
copy number loss |
not specified [RCV003986109] |
Chr19:18926463..21100330 [GRCh37] Chr19:19p13.11-12 |
uncertain significance |
NM_021267.5(CERS1):c.78C>T (p.Gly26=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003586896] |
Chr19:18895995 [GRCh38] Chr19:19006804 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.372C>T (p.Cys124=) |
single nucleotide variant |
not provided [RCV003554719] |
Chr19:18869344 [GRCh38] Chr19:18980153 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.996G>A (p.Lys332=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003588030] |
Chr19:18878944 [GRCh38] Chr19:18989753 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.901-8T>C |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV003586815] |
Chr19:18879047 [GRCh38] Chr19:18989856 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1043T>C (p.Leu348Pro) |
single nucleotide variant |
not provided [RCV003562417] |
Chr19:18868673 [GRCh38] Chr19:18979482 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.849C>G (p.Arg283=) |
single nucleotide variant |
not provided [RCV003562812] |
Chr19:18868867 [GRCh38] Chr19:18979676 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.729C>T (p.Gly243=) |
single nucleotide variant |
CERS1-related disorder [RCV003961439] |
Chr19:18880297 [GRCh38] Chr19:18991106 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.546G>T (p.Leu182=) |
single nucleotide variant |
GDF1-related disorder [RCV003896711] |
Chr19:18869170 [GRCh38] Chr19:18979979 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.665G>A (p.Arg222Gln) |
single nucleotide variant |
GDF1-related disorder [RCV003966894] |
Chr19:18869051 [GRCh38] Chr19:18979860 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.-263C>T |
single nucleotide variant |
GDF1-related disorder [RCV003949437] |
Chr19:18870570 [GRCh38] Chr19:18981379 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.267G>A (p.Pro89=) |
single nucleotide variant |
GDF1-related disorder [RCV003956935] |
Chr19:18870041 [GRCh38] Chr19:18980850 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.757C>T (p.Arg253Cys) |
single nucleotide variant |
not specified [RCV003995026] |
Chr19:18868959 [GRCh38] Chr19:18979768 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.341C>T (p.Ala114Val) |
single nucleotide variant |
not specified [RCV004387561] |
Chr19:18869375 [GRCh38] Chr19:18980184 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.23C>T (p.Ala8Val) |
single nucleotide variant |
not specified [RCV004428521] |
Chr19:18896050 [GRCh38] Chr19:19006859 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.260T>C (p.Leu87Pro) |
single nucleotide variant |
not specified [RCV004387559] |
Chr19:18870048 [GRCh38] Chr19:18980857 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.437G>A (p.Arg146His) |
single nucleotide variant |
not specified [RCV004387563] |
Chr19:18869279 [GRCh38] Chr19:18980088 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.938C>T (p.Pro313Leu) |
single nucleotide variant |
not specified [RCV004387564] |
Chr19:18868778 [GRCh38] Chr19:18979587 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.214G>A (p.Ala72Thr) |
single nucleotide variant |
not specified [RCV004428520] |
Chr19:18895859 [GRCh38] Chr19:19006668 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.619T>C (p.Phe207Leu) |
single nucleotide variant |
not specified [RCV004428522] |
Chr19:18880407 [GRCh38] Chr19:18991216 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.250G>A (p.Gly84Arg) |
single nucleotide variant |
not specified [RCV004387558] |
Chr19:18870058 [GRCh38] Chr19:18980867 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.416C>T (p.Ala139Val) |
single nucleotide variant |
not specified [RCV004387562] |
Chr19:18869300 [GRCh38] Chr19:18980109 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.134C>T (p.Ala45Val) |
single nucleotide variant |
not specified [RCV004428519] |
Chr19:18895939 [GRCh38] Chr19:19006748 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1076G>A (p.Arg359Gln) |
single nucleotide variant |
not provided [RCV004697643] |
Chr19:18868640 [GRCh38] Chr19:18979449 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.101C>T (p.Ala34Val) |
single nucleotide variant |
not specified [RCV004615082] |
Chr19:18895972 [GRCh38] Chr19:19006781 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.761A>G (p.Asp254Gly) |
single nucleotide variant |
not specified [RCV004626817] |
Chr19:18868955 [GRCh38] Chr19:18979764 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.861G>A (p.Ala287=) |
single nucleotide variant |
GDF1-related disorder [RCV004752339] |
Chr19:18868855 [GRCh38] Chr19:18979664 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.1066G>A (p.Val356Met) |
single nucleotide variant |
not provided [RCV004772126] |
Chr19:18868650 [GRCh38] Chr19:18979459 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.786C>T (p.Gly262=) |
single nucleotide variant |
not provided [RCV004727368] |
Chr19:18868930 [GRCh38] Chr19:18979739 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.187T>C (p.Trp63Arg) |
single nucleotide variant |
not provided [RCV004774248] |
Chr19:18870121 [GRCh38] Chr19:18980930 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1087G>C (p.Asp363His) |
single nucleotide variant |
GDF1-related disorder [RCV004752248] |
Chr19:18868629 [GRCh38] Chr19:18979438 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.817T>C (p.Tyr273His) |
single nucleotide variant |
GDF1-related disorder [RCV004752397] |
Chr19:18868899 [GRCh38] Chr19:18979708 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.328G>A (p.Ala110Thr) |
single nucleotide variant |
not provided [RCV004769336] |
Chr19:18869388 [GRCh38] Chr19:18980197 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.1052A>G (p.Asp351Gly) |
single nucleotide variant |
not provided [RCV005110310]|not specified [RCV004916695] |
Chr19:18868664 [GRCh38] Chr19:18979473 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.5C>A (p.Pro2Gln) |
single nucleotide variant |
not specified [RCV004916694] |
Chr19:18870303 [GRCh38] Chr19:18981112 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1010+10G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005105594] |
Chr19:18878920 [GRCh38] Chr19:18989729 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.655C>A (p.Leu219Ile) |
single nucleotide variant |
not specified [RCV004925257] |
Chr19:18869061 [GRCh38] Chr19:18979870 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.322C>G (p.Arg108Gly) |
single nucleotide variant |
not specified [RCV004925258] |
Chr19:18869986 [GRCh38] Chr19:18980795 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.928G>A (p.Gly310Arg) |
single nucleotide variant |
not provided [RCV005066034] |
Chr19:18868788 [GRCh38] Chr19:18979597 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.1010+7G>A |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005063751] |
Chr19:18878923 [GRCh38] Chr19:18989732 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.217G>A (p.Glu73Lys) |
single nucleotide variant |
not provided [RCV005054776] |
Chr19:18870091 [GRCh38] Chr19:18980900 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.687C>T (p.Gly229=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005174740] |
Chr19:18880339 [GRCh38] Chr19:18991148 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.794G>A (p.Gly265Asp) |
single nucleotide variant |
not specified [RCV004925256] |
Chr19:18868922 [GRCh38] Chr19:18979731 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_021267.5(CERS1):c.753-10C>G |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005082006] |
Chr19:18879398 [GRCh38] Chr19:18990207 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.409+9C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005132819] |
Chr19:18893407 [GRCh38] Chr19:19004216 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.249+12C>T |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005191782] |
Chr19:18895812 [GRCh38] Chr19:19006621 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.633C>T (p.Arg211=) |
single nucleotide variant |
not provided [RCV005122955] |
Chr19:18869083 [GRCh38] Chr19:18979892 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.924G>A (p.Lys308=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005184016] |
Chr19:18879016 [GRCh38] Chr19:18989825 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.951C>T (p.His317=) |
single nucleotide variant |
not provided [RCV005197545] |
Chr19:18868765 [GRCh38] Chr19:18979574 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.288G>C (p.Gly96=) |
single nucleotide variant |
not provided [RCV005181609] |
Chr19:18870020 [GRCh38] Chr19:18980829 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.735C>T (p.Cys245=) |
single nucleotide variant |
not provided [RCV005144762] |
Chr19:18868981 [GRCh38] Chr19:18979790 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.888C>G (p.Cys296Trp) |
single nucleotide variant |
not provided [RCV005194344] |
Chr19:18868828 [GRCh38] Chr19:18979637 [GRCh37] Chr19:19p13.11 |
uncertain significance |
NM_001492.6(GDF1):c.493C>T (p.Leu165=) |
single nucleotide variant |
not provided [RCV005143158] |
Chr19:18869223 [GRCh38] Chr19:18980032 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.6G>T (p.Ala2=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005138644] |
Chr19:18896067 [GRCh38] Chr19:19006876 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.90C>T (p.Pro30=) |
single nucleotide variant |
not provided [RCV005120815] |
Chr19:18870218 [GRCh38] Chr19:18981027 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.711G>A (p.Leu237=) |
single nucleotide variant |
not provided [RCV005132929] |
Chr19:18869005 [GRCh38] Chr19:18979814 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.648G>A (p.Ala216=) |
single nucleotide variant |
not provided [RCV005118036] |
Chr19:18869068 [GRCh38] Chr19:18979877 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.360C>T (p.Ala120=) |
single nucleotide variant |
not provided [RCV005194275] |
Chr19:18869356 [GRCh38] Chr19:18980165 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.865C>T (p.Leu289=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005205990] |
Chr19:18879276 [GRCh38] Chr19:18990085 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.30G>A (p.Pro10=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005133447] |
Chr19:18896043 [GRCh38] Chr19:19006852 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.762C>T (p.Asp254=) |
single nucleotide variant |
not provided [RCV005191728] |
Chr19:18868954 [GRCh38] Chr19:18979763 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_001492.6(GDF1):c.30C>A (p.Gly10=) |
single nucleotide variant |
not provided [RCV005108136] |
Chr19:18870278 [GRCh38] Chr19:18981087 [GRCh37] Chr19:19p13.11 |
likely benign |
NM_021267.5(CERS1):c.858G>A (p.Ala286=) |
single nucleotide variant |
Progressive myoclonic epilepsy type 8 [RCV005181169] |
Chr19:18879283 [GRCh38] Chr19:18990092 [GRCh37] Chr19:19p13.11 |
likely benign |